OXYGEN RESEARCH LIMITED

Company Registration Number:
03592469 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

OXYGEN RESEARCH LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

OXYGEN RESEARCH LIMITED

Balance sheet

As at 31 March 2025


Notes

2025

2024


£

£
Current assets
Debtors:   297 117
Cash at bank and in hand: 372,678 194,363
Total current assets: 372,975 194,480
Creditors: amounts falling due within one year:   (276,546) (33,091)
Net current assets (liabilities): 96,429 161,389
Total assets less current liabilities: 96,429 161,389
Total net assets (liabilities): 96,429 161,389
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 96,329 161,289
Shareholders funds: 96,429 161,389

The notes form part of these financial statements

OXYGEN RESEARCH LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 May 2025
and signed on behalf of the board by:

Name: Thomas Bayne
Status: Director

The notes form part of these financial statements

OXYGEN RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

OXYGEN RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 0 0

OXYGEN RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Related party transactions

Name of the related party: Thomas Bayne
Relationship:
Director
Description of the Transaction: Included in the sales are sales of £ 148,000 (£168,000) to Mountainview Learning Limited. Thomas Bayne is also a director and shareholder of this company.
£
Balance at 01 April 2024 0
Balance at 31 March 2025 0